Abbott’s medical devices EVP Lisa Earnhardt discusses the life science giant’s pivot during the COVID-19 pandemic.
In this week’s DeviceTalks Weekly Podcast, Abbott’s medical devices EVP Lisa Earnhardt explains how the life sciences giant pivoted during the pandemic. Earnhardt shares what programs were given greater priority when the lockdown’s impact became clear and why the company performed so well in one of its key businesses.
We also explore this week’s news that the FTC will oppose Illumina’s acquisition of Grail through interviews with Dr. Christopher Keir, vice president of medical affairs at Grail, and Vijay Kumar, senior managing director at Evercore ISI.
And, of course, Chris Newmarker, executive editor of MassDevice, delivers this week’s Newmarker’s Newsmakers, including news from Illumina, Grail, Corindus, Zimmer Biomet, BD, Medtronic and Abbott.
Final…